Anne Marie Wills - Publications

2005-2006 Neurology Harvard Medical School, Boston, MA, United States 

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Huh YE, Ruby Chiang MS, Locascio JJ, Liao Z, Liu G, Choudhury K, Kuras YI, Tuncali I, Videnovic A, Hunt AL, Schwarzschild MA, Hung AY, Herrington TM, Hayes MT, Hyman BT, ... Wills AM, et al. β-Glucocerebrosidase Activity in -linked Parkinson's Disease: The Type of Mutation Matters. Neurology. PMID 32540937 DOI: 10.1212/Wnl.0000000000009989  0.365
2020 Bakshi R, Macklin EA, Hung AY, Hayes MT, Hyman BT, Wills AM, Gomperts SN, Growdon JH, Ascherio A, Scherzer CR, Schwarzschild MA. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study. Journal of Parkinson's Disease. 10: 505-510. PMID 32250320 DOI: 10.3233/Jpd-191882  0.431
2020 Rotunno MS, Lane M, Zhang W, Wolf P, Oliva P, Viel C, Wills AM, Alcalay RN, Scherzer CR, Shihabuddin LS, Zhang K, Sardi SP. Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease. Scientific Reports. 10: 2479. PMID 32051502 DOI: 10.1038/S41598-020-59414-4  0.38
2020 Peterschmitt MJ, Saiki H, Hatano T, Gasser T, Isaacson S, Kulisevsky J, Simuni T, Takahashi Y, Wills A, Guedes LC, Svenningsson P, Takahashi R, Waters C, Katsuno M, Ji AJ, et al. Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 1 of the MOVES-PD study Molecular Genetics and Metabolism. 129: S128. DOI: 10.1016/J.Ymgme.2019.11.334  0.44
2019 Alcalay RN, Kehoe C, Shorr E, Battista R, Hall A, Simuni T, Marder K, Wills AM, Naito A, Beck JC, Schwarzschild MA, Nance M. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31680121 DOI: 10.1038/S41436-019-0684-X  0.376
2019 Mezoian T, Belt E, Garry J, Hubbard J, Breen CT, Miller L, Levine-Weinberg M, Nalipinski P, Sullivan S, Chan J, Wills AM. Loss of Appetite in ALS is Associated with Weight Loss and Decreased Calorie Consumption Independent of Dysphagia. Muscle & Nerve. PMID 31650547 DOI: 10.1002/Mus.26749  0.304
2019 Wills AM, Garry J, Hubbard J, Mezoian T, Breen CT, Ortiz-Miller C, Nalipinski P, Sullivan S, Berry JD, Cudkowicz M, Paganoni S, Chan J, Macklin EA. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. Bmc Neurology. 19: 104. PMID 31142272 DOI: 10.1186/S12883-019-1330-6  0.321
2019 Judith Peterschmitt M, Gasser T, Isaacson S, Kulisevsky J, Mir P, Simuni T, Wills A, Guedes LC, Svenningsson P, Waters C, Ji AJ, Li J, Minini P, Nembo B, Saubadu S, et al. Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation Molecular Genetics and Metabolism. 126: S117. DOI: 10.1016/J.Ymgme.2018.12.298  0.421
2018 Nicholson K, Chan J, Macklin EA, Levine-Weinberg M, Breen C, Bakshi R, Grasso DL, Wills AM, Jahandideh S, Taylor AA, Beaulieu D, Ennist DL, Andronesi O, Ratai EM, Schwarzschild MA, et al. Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 5: 1522-1533. PMID 30564619 DOI: 10.1002/Acn3.671  0.334
2017 Wills AM, Li R, Pérez A, Ren X, Boyd J. Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort. Journal of Neurology. PMID 28712000 DOI: 10.1007/S00415-017-8562-4  0.438
2017 Chou KL, Elm JJ, Wielinski CL, Simon DK, Aminoff MJ, Christine CW, Liang GS, Hauser RA, Sudarsky L, Umeh CC, Voss T, Juncos J, Fang JY, Boyd JT, Bodis-Wollner I, ... ... Wills AM, et al. Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort. Journal of the Neurological Sciences. 377: 137-143. PMID 28477684 DOI: 10.1016/J.Jns.2017.04.011  0.435
2017 Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, et al. Caffeine, creatine, GRIN2A and Parkinson's disease progression. Journal of the Neurological Sciences. 375: 355-359. PMID 28320167 DOI: 10.1016/J.Jns.2017.02.032  0.432
2017 Paganoni S, Macklin EA, Karam C, Yu H, Gonterman F, Fetterman KA, Cudkowicz M, Berry J, Wills AM. Vitamin D levels are associated with gross motor function in ALS. Muscle & Nerve. PMID 28044349 DOI: 10.1002/Mus.25555  0.312
2016 Wills AM, Boyd J, Pérez A. Association Between Body Mass Index and Parkinson Disease-Reply. Jama Neurology. PMID 27214659 DOI: 10.1001/Jamaneurol.2016.1245  0.346
2015 Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clinical Neuropharmacology. 38: 163-9. PMID 26366971 DOI: 10.1097/Wnf.0000000000000102  0.448
2015 Locascio JJ, Eberly S, Liao Z, Liu G, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Dhima K, Hung AY, Flaherty AW, Schwarzschild MA, Hayes MT, Wills AM, Shivraj Sohur U, Mejia NI, et al. Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain : a Journal of Neurology. 138: 2659-71. PMID 26220939 DOI: 10.1093/Brain/Awv202  0.39
2015 Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, ... ... Wills AM, et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Jama. 313: 584-93. PMID 25668262 DOI: 10.1001/Jama.2015.120  0.371
2014 Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, Hanes GP, Ladha SS, Heiman-Patterson T, Katz J, Lou JS, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet (London, England). 383: 2065-72. PMID 24582471 DOI: 10.1016/S0140-6736(14)60222-1  0.378
2013 Zhang M, Hubbard J, Rudnicki SA, Johansen CS, Dalton K, Heiman-Patterson T, Forshew DA, Wills AM. Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosis. E-Spen Journal. 8: e25-e28. PMID 25568837 DOI: 10.1016/J.Clnme.2012.11.003  0.316
2013 Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 81: 1531-7. PMID 24068787 DOI: 10.1212/Wnl.0B013E3182A95818  0.379
2013 Paganoni S, Wills AM. High-fat and ketogenic diets in amyotrophic lateral sclerosis. Journal of Child Neurology. 28: 989-92. PMID 23666040 DOI: 10.1177/0883073813488669  0.345
2012 Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. What does body mass index measure in amyotrophic lateral sclerosis and why should we care? Muscle & Nerve. 45: 612. PMID 22431098 DOI: 10.1002/Mus.22338  0.327
2012 Paganoni S, Zhang M, Quiroz Zárate A, Jaffa M, Yu H, Cudkowicz ME, Wills AM. Uric acid levels predict survival in men with amyotrophic lateral sclerosis. Journal of Neurology. 259: 1923-8. PMID 22323210 DOI: 10.1007/S00415-012-6440-7  0.348
2011 van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, Schulte C, Blauw HM, Koppers M, Diekstra FP, Fumoto K, LeClerc AL, Keagle P, Bloem BR, Scheffer H, ... ... Wills AM, et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Annals of Neurology. 70: 964-73. PMID 22190368 DOI: 10.1002/Ana.22611  0.475
2011 Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, et al. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2283-6. PMID 21953863 DOI: 10.1002/Mds.23934  0.418
2011 Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle & Nerve. 44: 20-4. PMID 21607987 DOI: 10.1002/Mus.22114  0.351
2011 Ticozzi N, LeClerc AL, van Blitterswijk M, Keagle P, McKenna-Yasek DM, Sapp PC, Silani V, Wills AM, Brown RH, Landers JE. Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiology of Aging. 32: 2096-9. PMID 20031275 DOI: 10.1016/J.Neurobiolaging.2009.11.018  0.422
2009 Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, Sapp PC, van Vught PW, McKenna-Yasek DM, Blauw HM, Cho TJ, Polak M, Shi L, Wills AM, Broom WJ, et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 9004-9. PMID 19451621 DOI: 10.1073/Pnas.0812937106  0.321
2005 Wills AM, Plante DT, Dukkipati SR, Corcoran CP, Standaert DG. Pacemaker-induced tachycardia caused by inappropriate response to parkinsonian tremor. Neurology. 65: 1676-7. PMID 16301511 DOI: 10.1212/01.wnl.0000184489.74795.b2  0.495
Show low-probability matches.